drugset / Trial / NCT01023711

Immunologic Response to Inactivated Vaccine for Novel H1N1 Virus

NCT01023711

Completed 107 enrolled University of Rochester
NaSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to describe the immune response to a novel H1N1 influenza vaccination in healthy adults, and to understand the factors that allow healthy adults to respond to a single dose of vaccine even if they have never previously experience novel H1N1 disease or vaccination.

Timeline

Start
2009-11
Primary completion
2010-11
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Inactivated H1N1 Vaccine Vaccine 0.5 ml Intramuscular

Indications